Unapproved Devices Medical Equipment Fraud Attorneys

Nolan Auerbach & White is an experienced Medical Equipment Fraud Law Firm helping courageous whistleblowers.

Since 1976, the FDA has had the responsibility to be the medical device gatekeeper, approving or clearing devices for interstate commerce. Unfortunately, the bureaucratic agency has not been able to keep up with the rapidly changing medical device landscape. Too, the FDA regulatory gates have been pried open by Congress, leading to a flood of medically-questionable devices in the market.

According to one expert, “Many high-risk medical devices today are approved on the basis of just one clinical trial (as opposed to new medications which usually require two trials).  And only a small minority of clinical studies of medical devices are randomized, controlled and blinded—the gold standard for reliable evidence (and the benchmark to which studies of drugs are held).”

Even in this lenient environment, many medical device manufacturers are finding it necessary to cheat the FDA, either by fabricating pivotal trial results or by otherwise misrepresenting factual data in the FDA approval or clearance processes. These actions may subject the manufacturer to liability under the False Claims Act and the federal Food, Drug and Cosmetic Act (FDCA).

Under the FDCA, every manufacturer of a medical device is required to obtain authorization from the FDA prior to marketing its device, unless the devices are subject to certain rare exemptions. If the manufacturer intends to market a previously cleared device for a new or different indication for use other than the intended use cleared by the FDA, a new marketing authorization is required. While physicians may prescribe medical devices for unapproved uses, a manufacturer may not distribute medical devices in interstate commerce with the intent that those devices be used for unapproved purposes.

By filing successful qui tam actions against manufacturers that engage in FDA fraud, Nolan Auerbach & White has been at the forefront in helping the government recoup hundreds of millions of healthcare dollars wasted on unapproved drugs. The Firm has also scrutinized the same devious business practices in medical device industry, in which manufacturers market their devices without FDA approval or for uses not approved or cleared by the FDA. Given that many of these devices are used in medically invasive procedures, the Firm and the federal government have a special interest in exposing these manufacturers.

Kathleen Hawkins

Dignity Health
$37 million

Kathleen Hawkins, RN MSN, had been employed by Defendant, Catholic Healthcare West (CHW) for approximately 6 years when she decided she had had enough of trying to change the hospital system from within.

CHW, a California not-for-profit corporation that operated hospitals in California, Arizona, and Nevada, was at the time the eighth largest hospital system in the nation and the largest not-for-profit hospital provider in California.

CLICK FOR MORE

Joe Strom

Johnson & Johnson
$184 Million

Joe Strom contacted us in 2005. We were very grateful that he did. We immediately formed an all-star legal team and a process to stop a very harmful pharmaceutical marketing strategy. It was this process we set into motion that ultimately returned hundreds of millions of dollars to the U.S. Treasury, and a portion of that, very well-deserved, into Joe’s bank account.

Joe told us a very troubling story about the off-label promotion of a pharmaceutical drug for patients who already suffered from chronic heart failure.

CLICK FOR MORE

Bruce A. Moilan Sr.

$27 Million

Bruce Moilan was a seasoned hospital systems expert by the time he contacted our Firm. At the time he decided to file his qui tam lawsuit, he was employed by South Texas Health System as a System Director for Materials Management. In this position, he oversaw $24 million in annual purchases of supplies and equipment and helped determine budget, reduction and cost analysis throughout the contract bidding and negotiations process. His job was to insure proper implementation for purchasing, receiving and management of inventory, for McAllen Hospitals, L.P.

CLICK FOR MORE

Description
Description
Description
Contact Us